| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 273.16 | 300.54 | 367.69 | 114.52 |
Depreciation | -99.97 | -107.39 | -82.59 | -81.12 |
Tax paid | -58.69 | 22.3 | -104.25 | -35.32 |
Working capital | -964.78 | 534.81 | -82.75 | -63.88 |
Other operating items | ||||
Operating | -850.27 | 750.25 | 98.09 | -65.81 |
Capital expenditure | -2,139.47 | 603.56 | 97.65 | 85.61 |
Free cash flow | -2,989.74 | 1,353.81 | 195.75 | 19.79 |
Equity raised | 3,643.41 | 4,503.67 | 4,044.67 | 3,993.27 |
Investing | -118.05 | 57.73 | -3.34 | 0.39 |
Financing | 718.5 | 1,976.32 | 1,015.76 | 839.51 |
Dividends paid | 0 | 0 | 47.78 | 47.78 |
Net in cash | 1,254.11 | 7,891.54 | 5,300.63 | 4,900.75 |
This FDA audit confirms compliance with regulatory standards, enhancing the credibility of Jubilant's operations in the United States.
Jubilant Pharmova Ltd has gained a total of 126% in the last one year, and almost 75% gain since the beginning of the year.
Here are some of the stocks that may see significant price movement today: Tata Motors, Reliance Industries, IREDA, etc.
Drug company Jubilant Pharmova Ltd will acquire an 80% stake in Pierre Fabre Laboratories' Research & Development Centre in Saint Julien, France.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
